Quantbot Technologies LP Cerevel Therapeutics Holdings, Inc. Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$25.35 - $31.96 $219,201 - $276,358	8,647 New	8,647 $272,000
Q1 2022 May 16, 2022	SELL	$23.5 - $35.38 $54,050 - $81,374	-2,300 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$29.21 - $44.64 $35,052 - $53,568	1,200 Added 109.09%	2,300 $74,000
Q3 2021 Nov 09, 2021	BUY	$21.26 - $38.85 $23,386 - $42,735	1,100 New	1,100 $32,000

5.01M

3.3K

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.